Seung Won Kim
Overview
Explore the profile of Seung Won Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Park J, An H, Lim J, Park I, Kim M, Kim J, et al.
Arthritis Res Ther
. 2023 Mar;
25(1):33.
PMID: 36864496
Background: Clonal haematopoiesis of indeterminate potential (CHIP) is a predisposition to haematological malignancy whose relationship with chronic inflammatory diseases, such as cardiovascular diseases, has been highlighted. Here, we aimed to...
12.
Kim S, Lee J, Lee H, Ahn J, Kim J, Park I, et al.
Gut Liver
. 2023 Feb;
17(6):905-915.
PMID: 36814356
Background/aims: Crohn's disease (CD) with recurrent inflammation can cause intestinal fibrostenosis due to dysregulated deposition of extracellular matrix. However, little is known about the pathogenesis of fibrostenosis. Here, we performed...
13.
Ma H, Kim J, Kim D, Park I, Kim J, Park K, et al.
Cancer Gene Ther
. 2022 Dec;
30(5):694-703.
PMID: 36577836
Development of colorectal cancer (CRC) is regulated by a series of genetic and microenvironmental alterations. Olfactomedin 4 (OLFM4) is a secreted glycoprotein that is highly expressed in the gastrointestinal tract...
14.
Kim J, Yoo J, Ma H, Park I, Son M, Shin Y, et al.
Intest Res
. 2022 Nov;
21(2):266-269.
PMID: 36366930
No abstract available.
15.
Lee J, Ma H, Kim J, Park I, Son M, Ryu K, et al.
Gut Liver
. 2022 Sep;
17(5):766-776.
PMID: 36167345
Background/aims: The purpose of the current study was to examine the anti-inflammatory effects of CKD-506, a novel histone deacetylase 6 inhibitor, on human peripheral blood mononuclear cells (PBMCs) and CD4+...
16.
Son M, Park I, Kim S, Ma H, Kim J, Kim T, et al.
Front Immunol
. 2022 Jun;
13:870817.
PMID: 35693794
Inflammatory bowel disease (IBD) is a chronic immune-mediated disorder characterized by prolonged inflammation of the gastrointestinal tract. IBD can result from gut barrier dysfunction, altered gut microbiota, and abnormal intestinal...
17.
Park J, Kim D, Kim S, Ma H, Park I, Son M, et al.
Intest Res
. 2021 Nov;
19(4):478-481.
PMID: 34731563
No abstract available.
18.
Fremder M, Kim S, Khamaysi A, Shimshilashvili L, Eini-Rider H, Park I, et al.
Cell Rep
. 2021 Aug;
36(6):109521.
PMID: 34380041
The gut metabolite composition determined by the microbiota has paramount impact on gastrointestinal physiology. However, the role that bacterial metabolites play in communicating with host cells during inflammatory diseases is...
19.
Kim D, Park J, Kim S, Yoon M, Ma H, Park I, et al.
Free Radic Biol Med
. 2021 Aug;
174:110-120.
PMID: 34358646
Background: Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract whose occurrence is attributed to various factors, including genetic factors, immune response, microbial changes, and oxidative...
20.
Kim S, Woo H, Kim E, Kim H, Suh H, Kim S, et al.
Prog Neurobiol
. 2021 May;
204:102086.
PMID: 34052305
Successful clinical translation of stem cell-based therapy largely relies on the scalable and reproducible preparation of donor cells with potent therapeutic capacities. In this study, midbrain organoids were yielded from...